Search

Your search keyword '"Cotter, Gad"' showing total 1,386 results

Search Constraints

Start Over You searched for: Author "Cotter, Gad" Remove constraint Author: "Cotter, Gad"
1,386 results on '"Cotter, Gad"'

Search Results

1. Insights on prevalence and incidence of anemia and rapid up-titration of oral heart failure treatment from the STRONG-HF study

2. Titration of Medications After Acute Heart Failure Is Safe, Tolerated, and Effective Regardless of Risk

3. Characteristics, treatment, and outcomes of early vs. late enrollees of the STRONG-HF trial

6. Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF Trial

7. Worsening renal function in acute heart failure in the context of diuretic response

8. Noninvasive measure of treatment response in non‐alcoholic steatohepatitis: Insights from EMMINENCE and meta‐analysis

9. Objectively measured medication adherence using assays for carvedilol and enalaprilat in patients with heart failure in Mozambique and Nigeria

11. Hepatorenal dysfunction identifies high‐risk patients with acute heart failure: insights from the RELAX‐AHF trial

12. Reduced congestion and improved response to a fluid/sodium challenge in chronic heart failure patients after initiation of sacubitril/valsartan: The NATRIUM‐HF study

13. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial

14. Association between in-ICU red blood cells transfusion and 1-year mortality in ICU survivors

15. Burst steroid therapy for acute heart failure: The CORTAHF randomized, open‐label, pilot trial.

16. Decongestion in acute heart failure: Is it time to change diuretic‐centred paradigm?

17. Outcomes of patients with heart failure with preserved ejection fraction discharged on treatment with neurohormonal antagonists after an episode of decompensation

19. Impact of Rapid Up-Titration of Guideline-Directed Medical Therapies on Quality of Life: Insights From the STRONG-HF Trial

20. Blood pressure and intensive treatment up‐titration after acute heart failure hospitalization: Insights from the STRONG‐HF trial

21. Safety Indicators In Patients Receiving High-intensity Care After Acute Heart Failure Admission: The STRONG-HF Trial

23. Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF)

24. Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX‐AHF‐2 study

25. Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial.

26. Identifying Subpopulations with Distinct Response to Treatment Using Plasma Biomarkers in Acute Heart Failure: Results from the PROTECT Trial

27. Sex differences in early dyspnea relief between men and women hospitalized for acute heart failure: insights from the RELAX-AHF study

28. Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial

29. Corticosteroid burst therapy in patients with acute heart failure: Design of the CORTAHF pilot study.

30. Cause of Death in Patients With Acute Heart Failure: Insights From RELAX-AHF-2

32. Effects of serelaxin in acute heart failure patients with renal impairment: results from RELAX-AHF.

33. A combined clinical and biomarker approach to predict diuretic response in acute heart failure

34. Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission

35. Effective medications can work only in patients who take them: implications for post acute heart failure care

36. Cell Therapy Improves Quality-of-Life in Heart Failure: Outcomes From a Phase III Clinical Trial

37. Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF Trial

39. C‐reactive protein, inflammation and short‐term mortality in acute heart failure.

41. Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the PROTECT trial

42. International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short‐term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial

44. Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission: A Secondary Analysis of the STRONG-HF Randomized Clinical Trial.

45. Medical therapy of cardiogenic shock: Contemporary use of inotropes and vasopressors.

46. Effective medications can work only in patients who take them: Implications for post‐acute heart failure care.

47. Noncardiac comorbidities and intensive up‐titration of oral treatment in patients recently hospitalized for heart failure: insights from the STRONG‐HF trial

Catalog

Books, media, physical & digital resources